MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
93 hedge funds and large institutions have $272M invested in Merrimack Pharmaceuticals, Inc. in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 20
Holders
93
Holding in Top 10
–
Calls
$2.5M
Puts
$731K
Top Buyers
| 1 | +$5.8M | |
| 2 | +$5.74M | |
| 3 | +$4.99M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.78M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$3.12M |
Top Sellers
| 1 | -$12.2M | |
| 2 | -$7.1M | |
| 3 | -$5.34M | |
| 4 |
O
OppenheimerFunds
New York
|
-$2.83M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$2.29M |